Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-3102875.0%
operating margin TTM
-1678575.0%
revenue TTM
729
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | -0.00 |
| price to sales ratio | 248.75 |
| enterprise value multiple | 0.27 |
| price fair value | -0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -1678575.0% |
| pretax profit margin | -3110600.0% |
| net profit margin | -3102875.0% |
| return on assets | -397.61% |
| return on equity | 121.86% |
| return on capital employed | 211.43% |
liquidity ratios | |
|---|---|
| current ratio | 0.30 |
| quick ratio | 0.30 |
| cash ratio | 0.24 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 75,737.50 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 75,737.50 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.52 |
| debt equity ratio | -0.47 |
| long term debt to capitalization | -0.76 |
| total debt to capitalization | -0.88 |
| interest coverage | -6.84 |
| cash flow to debt ratio | -1.02 |
cash flow ratios | |
|---|---|
| free cash flow per share | -30.81 |
| cash per share | 9.64 |
| operating cash flow per share | -30.75 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.02 |
| short term coverage ratios | -24.54 |
| capital expenditure coverage ratio | -470.86 |
Frequently Asked Questions
When was the last time Biora Therapeutics, Inc. (NASDAQ:BIOR) reported earnings?
Biora Therapeutics, Inc. (BIOR) published its most recent earnings results on 14-11-2024.
What is Biora Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Biora Therapeutics, Inc. (NASDAQ:BIOR)'s trailing twelve months ROE is 121.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Biora Therapeutics, Inc. (BIOR) currently has a ROA of -397.61%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIOR's net profit margin stand at?
BIOR reported a profit margin of -3102875.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIOR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.30 in the most recent quarter. The quick ratio stood at 0.30, with a Debt/Eq ratio of -0.47.